Today, I came across a 2014 article by H. Huang et al. from Harvard Medical School titled “A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.” published in General Hospital Psychiatry that examined the relationship between gestational exposure to selective serotonin reuptake inhibitor drugs (SSRIs) and low birth weight, preterm birth, and otherwise poor neonatal outcomes.
In this study, Huang reviewed previously-published studies and used statistics to normalize data, creating what is known in research as a “meta-analysis.” “Of the 222 reviewed studies, 28 published studies met the selection criteria.”
Results showed that “Using random-effects models, antidepressant use in pregnancy was significantly associated with LBW (RR: 1.44, 95% confidence interval (CI): 1.21-1.70) and PTB (RR: 1.69, 95% CI: 1.52-1.88).” To be clear, “RR” stands for Relative Risk: these results showed that babies born to mothers who used antidepressants in pregnancy were 44% more likely to have low birth weight, and 69% more likely to be born prematurely.
As such, the researchers concluded that “Antidepressant use during pregnancy significantly increases the risk for LBW and PTB.”
Because so many women have used SSRIs while pregnant due to the fact that SSRI manufacturers have failed time and again to warn of these and other serious risks, SSRI birth defect lawsuits have filed around the world in great number.
If you or a loved one used SSRIs and gave birth to a child with a birth defect or poor birth outcome, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the compassion, resources, and experience required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529